I. Introduction On 30 June 2009, the Athens Administrative Court of Appeal (Dioikitiko Efeteio Athinon, hereafter: the Court) delivered Decision No 2019/2009 annulling partially Decision No 318/V/2006 [1] of the Hellenic Competition Commission (Elliniki Epitropi Antagonismou, hereafter: HCC) to the extent it had found that (1) the pharmaceutical company GlaxoSmithKline (hereafter: GSK) had not infringed Art 82 EC (now Art 102 TFEU) from November 2000 through February 2001 and (2) GSK had complied with the prior Decision No 193/III/2001. Furthermore, the Court recognized that the said company abused its dominant position regarding the drug Lamictal and infringed both Art 2 Act 703/1977 (Hellenic Act on the control of monopolies and oligopolies and on the protection of free
Share on
|
|
The Athens Administrative Court of Appeal partially annuls the decision of the Competition Commission on the parallel trade of pharmaceuticals (GlaxoSmithKline)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
